Accessibility Menu
 
Bonus BioGroup logo

Bonus BioGroup

(OTC) BBIXF

Current Price$0.13
Market Cap$151.86M
Since IPO (2019)+1%
5 Year+30%
1 Year+333%
1 Month+8%

Bonus BioGroup Financials at a Glance

Market Cap

$151.86M

Revenue (TTM)

$0.00

Net Income (TTM)

$25.52M

EPS (TTM)

$-0.01

P/E Ratio

-21.31

Dividend

$0.00

Beta (Volatility)

15.76 (High)

Price

$0.13

Volume

2,500

Open

$0.13

Previous Close

$0.13

Daily Range

$0.13 - $0.13

52-Week Range

$0.00 - $0.15

BBIXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bonus BioGroup

Industry

Biotechnology

Employees

49

CEO

Shai Meretzki, PhD

Headquarters

Haifa, 31905, IL

BBIXF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-1%

Earnings Yield

-4.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$151.86M

Shares Outstanding

1.17B

Volume

2.50K

Avg. Volume

876

Financials (TTM)

Gross Profit

$2.74M

Operating Income

$22.53M

EBITDA

$19.78M

Operating Cash Flow

$14.86M

Capital Expenditure

$11.94K

Free Cash Flow

$14.87M

Cash & ST Invst.

$226.91K

Total Debt

$8.86M

Bonus BioGroup Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$151.86M

N/A

Market Cap/Employee

$3.10M

N/A

Employees

49

N/A

Net Income

$6.33M

+10.2%

EBITDA

$5.44M

+11.5%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$8.41M

-345.7%

Accounts Receivable

$1.15M

+162.2%

Inventory

$0.00

N/A

Long Term Debt

$7.88M

-13.9%

Short Term Debt

$1.73M

+9.4%

Return on Assets

-1.07%

N/A

Return on Invested Capital

-2.89%

N/A

Free Cash Flow

$4.03M

+34.3%

Operating Cash Flow

$4.02M

+33.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CLCSCell Source, Inc.
$0.84+2.74%
IPDQFImpediMed Limited
$0.01+72.84%
RVXCFResverlogix Corp.
$0.08+0.00%
CLYYFCelyad Oncology S.A.
$0.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%

Questions About BBIXF

What is the current price of Bonus BioGroup?

Bonus BioGroup is trading at $0.13 per share.

What is the 52-week range for Bonus BioGroup?

Over the past 52 weeks, Bonus BioGroup has traded between $0.00 and $0.15.

How much debt does Bonus BioGroup have?

As of the most recent reporting period, Bonus BioGroup reported total debt of $2.80M.

How much cash does Bonus BioGroup have on hand?

Bonus BioGroup reported $1.88M in cash and cash equivalents in its most recent financial results.

What is Bonus BioGroup’s dividend yield?

Bonus BioGroup does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.